Pitfalls and Problems of the Long Term Use of Neuroleptic Drugs in Schizophrenia
- 1 February 1993
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 8 (2) , 136-148
- https://doi.org/10.2165/00002018-199308020-00004
Abstract
Although acute and immediate extrapyramidal syndromes are common and, in the case of neuroleptic malignant syndrome, may have serious sequelae, the most important problem with psychotropic medication...Keywords
This publication has 57 references indexed in Scilit:
- The association between the neuroleptic malignant syndrome and malignant hyperthermiaActa Anaesthesiologica Scandinavica, 1989
- Neuroleptic malignant syndrome. Review of response to therapyArchives of internal medicine (1960), 1989
- A comparison of severe tardive dystonia and severe tardive dyskinesiaActa Psychiatrica Scandinavica, 1989
- Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesiaPsychological Medicine, 1989
- A Clinical Trial of the Efficacy and Acceptability of d-Fenfluramine in the Treatment of Neuroleptic-induced ObesityThe British Journal of Psychiatry, 1988
- Heterogeneity of Tardive DyskinesiaThe British Journal of Psychiatry, 1988
- Idiopathic Parkinsonʼs Disease in a Chronic Schizophrenic PatientClinical Neuropharmacology, 1987
- Depression ‘Revealed’ in SchizophreniaThe British Journal of Psychiatry, 1982
- The Abrupt Withdrawal of Antiparkinsonian Drugs in Schizophrenic PatientsThe British Journal of Psychiatry, 1974
- Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind PlaceboBMJ, 1973